Sector NewAmsterdam Pharma Company N.V. Nasdaq
Stocks
NAMS
NL00150012L7
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 22.49 USD | +2.55% |
|
-1.36% | -35.89% |
| 08-26 | NewAmsterdam Pharma Presents Data From Obicetrapib Development Program At European Society Of Cardiology Congress 2026 | CI |
| 08-14 | Newamsterdam Pharma Company N.V. Announces Executive Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.31% | +5.79% | -2.44% | +55.76% | +76.52% | +47.13% | +99.00% | +4.99% | - | 70.88B | |
| +0.39% | +2.06% | -0.71% | +12.61% | +21.57% | +39.38% | +78.27% | +211.10% | +5,709.33% | 62.49B | |
| +0.50% | +7.13% | +5.11% | +63.37% | +60.15% | +33.27% | +16.01% | -59.10% | - | 26.34B | |
| -3.21% | -7.27% | -8.16% | +25.26% | -31.05% | -17.10% | +356.10% | +348.10% | +724.74% | 26.21B | |
| -2.64% | -0.69% | -15.08% | +5.69% | +0.90% | -0.17% | -13.01% | -73.26% | - | 24.13B | |
| +0.71% | +8.03% | +5.02% | +38.10% | +11.49% | +25.03% | -12.74% | -16.30% | +105.83% | 20.72B | |
| -1.26% | -7.81% | -15.71% | +23.49% | +178.50% | +156.15% | +320.43% | +1,409.96% | +713.77% | 15.36B | |
| -0.22% | +3.99% | +7.30% | +12.43% | +33.15% | +45.54% | +172.46% | +181.66% | +327.86% | 14.46B | |
| +0.73% | +1.71% | +36.16% | +29.82% | +2.06% | -5.51% | +849.47% | +179.78% | +159.45% | 14.24B | |
| +0.04% | -0.77% | -11.82% | +11.01% | +17.70% | -9.40% | +477.72% | - | - | 14.06B | |
| -0.54% | -0.56% | -1.60% | +5.10% | -8.73% | +20.82% | +213.86% | +550.26% | +5,285.21% | 12.28B | |
| -0.28% | +0.22% | +1.34% | +3.37% | -19.91% | -30.22% | +139.42% | +112.19% | - | 10.63B | |
| -1.63% | -6.76% | -11.53% | -12.69% | +8.25% | +41.35% | +108.87% | +102.95% | +704.44% | 9.56B | |
| -1.86% | -19.76% | -25.65% | -18.75% | +0.14% | +116.62% | +144.14% | +2.39% | +838.98% | 9.39B | |
| +0.24% | +7.21% | +4.31% | +15.22% | +328.28% | +210.62% | +373.74% | -16.70% | - | 8.99B | |
| -3.71% | -2.25% | -8.17% | +13.01% | +25.99% | +83.09% | +15.79% | +129.22% | - | 8.65B | |
| +0.81% | +1.29% | -4.17% | +9.05% | +3.75% | -28.10% | +83.99% | -27.26% | - | 8.04B | |
| -2.62% | -0.39% | -17.14% | +2.16% | +175.49% | +506.52% | +651.46% | -51.67% | -47.98% | 7.96B | |
| +0.36% | -1.63% | +1.43% | +17.00% | +6.88% | +143.53% | +448.83% | - | - | 6.88B | |
| Average | -0.76% | -0.45% | -3.24% | +16.37% | +46.90% | +72.55% | +238.09% | +175.78% | +1,452.16% | 19.54B | |
| Weighted average by Cap. | -0.58% | +0.46% | -2.40% | +25.25% | +42.32% | +49.62% | +178.48% | +157.43% | +2,465.87% |
- Stock Market
- Stocks
- NAMS Stock
- NAMS Stock
- Sector NewAmsterdam Pharma Company N.V.
Select your edition
All financial news and data tailored to specific country editions
